Mirae Asset Global Etfs Holdings Ltd. Crispr Therapeutics Ag Transaction History
Mirae Asset Global Etfs Holdings Ltd.
- $43.9 Billion
- Q4 2024
A detailed history of Mirae Asset Global Etfs Holdings Ltd. transactions in Crispr Therapeutics Ag stock. As of the latest transaction made, Mirae Asset Global Etfs Holdings Ltd. holds 79,967 shares of CRSP stock, worth $3.98 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
79,967
Previous 65,842
21.45%
Holding current value
$3.98 Million
Previous $3.09 Million
1.75%
% of portfolio
0.01%
Previous 0.01%
Shares
3 transactions
Others Institutions Holding CRSP
# of Institutions
494Shares Held
64.3MCall Options Held
1.68MPut Options Held
1.95M-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl8.97MShares$446 Million3.09% of portfolio
-
Capital International Investors Los Angeles, CA8.74MShares$435 Million0.07% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD3.81MShares$190 Million0.09% of portfolio
-
Black Rock Inc. New York, NY2.78MShares$138 Million0.0% of portfolio
-
Nikko Asset Management Americas, Inc.2.75MShares$137 Million1.21% of portfolio
About CRISPR Therapeutics AG
- Ticker CRSP
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 78,009,296
- Market Cap $3.88B
- Description
- CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious diseases using its proprietary Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. Its CRISPR/Cas9 is a gene editing technology that allows for precise directed changes to genomic DNA....